Promontory Therapeutics to Present Research on the Immunological Effects of PT-112 in Cancer Cell Mitochondria at SITC 2022

NEW YORK, Nov. 7, 2022 /PRNewswire/ -- Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunotherap...

Related Keywords

United States ,China ,Germany ,Canada ,Stephanie Carrington ,Takahiro Yamazaki ,Alexis Feinberg ,Taylorb Young ,Lorenzo Galluzzi ,Promontory Therapeutics Inc ,Prnewswire Promontory Therapeutics Inc ,Merck Kga ,Merck Kgaa ,Serono ,Virtual Congress ,Strategic Development ,Therapeutics Inc ,Annual Meeting ,Presentation Sessions ,Promontory Therapeutic ,Developmental Therapeutics ,Orphan Drug ,Promontory Therapeutics ,